{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T16:35:39Z","timestamp":1695573339306},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,5,20]],"date-time":"2016-05-20T00:00:00Z","timestamp":1463702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1038\/leu.2016.117","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T19:21:25Z","timestamp":1463858485000},"page":"1795-1796","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of azacitidine in higher-risk myelodysplastic syndromes"],"prefix":"10.1038","volume":"30","author":[{"given":"A G","family":"Dinmohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"van Norden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A A","family":"van de Loosdrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Jongen-Lavrencic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,20]]},"reference":[{"key":"BFleu2016117_CR1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1038\/leu.2015.220","volume":"29","author":"AG Dinmohamed","year":"2015","unstructured":"Dinmohamed AG, van Norden Y, Visser O, Posthuma EF, Huijgens PC, Sonneveld P et al. Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry. Leukemia 2015; 29: 2449\u20132451.","journal-title":"Leukemia"},{"key":"BFleu2016117_CR2","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1038\/leu.2015.115","volume":"29","author":"T Bernal","year":"2015","unstructured":"Bernal T, Martinez-Camblor P, Sanchez-Garcia J, de Paz R, Luno E, Nomdedeu B et al. Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry. Leukemia 2015; 29: 1875\u20131881.","journal-title":"Leukemia"},{"key":"BFleu2016117_CR3","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/leu.2015.339","volume":"30","author":"T Bernal","year":"2016","unstructured":"Bernal T, Martinez-Camblor P, Sanchez-Garcia J, Sanz G . Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply. Leukemia 2016; 30: 740\u2013741.","journal-title":"Leukemia"},{"key":"BFleu2016117_CR4","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1200\/JCO.2011.39.6499","volume":"30","author":"JJ Cornelissen","year":"2012","unstructured":"Cornelissen JJ, Breems D, van Putten WL, Gratwohl AA, Passweg JR, Pabst T et al. Comparative analysis of the value of allogeneic hematopoietic stem-cell transplantation in acute myeloid leukemia with monosomal karyotype versus other cytogenetic risk categories. J Clin Oncol 2012; 30: 2140\u20132146.","journal-title":"J Clin Oncol"},{"key":"BFleu2016117_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/leu.2014.332","volume":"29","author":"JJ Cornelissen","year":"2015","unstructured":"Cornelissen JJ, Versluis J, Passweg JR, van Putten WL, Manz MG, Maertens J et al. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia 2015; 29: 1041\u20131050.","journal-title":"Leukemia"},{"key":"BFleu2016117_CR6","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/S2352-3026(15)00148-9","volume":"2","author":"J Versluis","year":"2015","unstructured":"Versluis J, Hazenberg CL, Passweg JR, van Putten WL, Maertens J, Biemond BJ et al. Post-remission treatment with allogeneic stem cell transplantation in patients aged 60 years and older with acute myeloid leukaemia: a time-dependent analysis. Lancet Haematol 2015; 2: e427\u2013e436.","journal-title":"Lancet Haematol"},{"key":"BFleu2016117_CR7","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/leu.2014.319","volume":"29","author":"NH Russell","year":"2015","unstructured":"Russell NH, Kjeldsen L, Craddock C, Pagliuca A, Yin JA, Clark RE et al. A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia. Leukemia 2015; 29: 1478\u20131484.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2016117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016117","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2016117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:06:33Z","timestamp":1648742793000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2016117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,20]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["BFleu2016117"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.117","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,20]]},"assertion":[{"value":"20 May 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}